Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows From Operating Activities
Net income	$ 10,215	$ 11,694
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	46,081	47,408
Gain on disposition of property	0	(15,696)
Amortization of non-cash items within interest expense	2,076	2,238
Amortization of acquired above- and below-market leases, net	(514)	(703)
Amortization of acquired below-market ground leases	1,958	1,958
Straight-lining of rental revenue	(3,061)	(556)
Equity based compensation	3,449	4,374
Loss on early extinguishment of debt	553	0
Increase (decrease) in cash flows due to changes in operating assets and liabilities:
Security deposits	(10,042)	10,184
Tenant and other receivables	(1,371)	258
Deferred leasing costs	(8,105)	(4,498)
Prepaid expenses and other assets	29,132	34,915
Accounts payable and accrued expenses	141	(6,804)
Deferred revenue and other liabilities	414	1,591
Net cash provided by operating activities	70,926	86,363
Cash Flows From Investing Activities
Acquisition of non-controlling interests in other partnerships	(14,226)	0
Net proceeds from disposition of property	0	39,137
Post-closing costs from a prior period sale of property	(4,034)	0
Development costs	(9)	(12)
Additions to building and improvements	(53,000)	(41,756)
Net cash used in investing activities	(71,269)	(2,631)
Cash Flows From Financing Activities
Repayment of mortgage notes payable	(1,470)	(2,142)
Proceeds from unsecured term loan	95,000	0
Repayment of unsecured term loan	(215,000)	0
Proceeds from unsecured revolving credit facility	120,000	0
Deferred financing costs	(9,280)	0
Repurchases of common shares	0	(5,694)
Private perpetual preferred unit distributions	(1,050)	(1,050)
Dividends paid to common stockholders	(5,765)	(5,675)
Distributions paid to non-controlling interests in the operating partnership	(3,737)	(3,018)
Net cash used in financing activities	(21,302)	(17,579)
Net increase (decrease) in cash and cash equivalents and restricted cash	(21,645)	66,153
Cash and cash equivalents and restricted cash—beginning of period	406,956	314,678
Cash and cash equivalents and restricted cash—end of period	385,311	380,831
Reconciliation of Cash and Cash Equivalents and Restricted Cash:
Cash and cash equivalents at beginning of period	346,620	264,434
Restricted cash at beginning of period	60,336	50,244
Cash and cash equivalents at end of period	333,573	272,648
Restricted cash at end of period	51,738	108,183
Cash and cash equivalents and restricted cash	385,311	380,831
Supplemental disclosures of cash flow information:
Cash paid for interest	21,984	23,006
Cash paid for income taxes	480	283
Non-cash investing and financing activities:
Building and improvements included in accounts payable and accrued expenses	48,771	39,982
Write-off of fully depreciated assets	551	847
Derivative instruments at fair values included in prepaid expenses and other assets	16,726	12,446
Derivative instruments at fair values included in accounts payable and accrued expenses	0	2,171
Conversion of operating partnership units and Class B shares to Class A shares	$ 7,132	$ 2,544